Vasen, Hans F A

Revised guidelines for the clinical management of Lynch syndrome (HNPCC): recommendations by a group of European experts

Vasen, H. F. A., Blanco, I., Aktan-Collan, K., Gopie, J. P., Alonso, A., Aretz, S., Bernstein, I., Bertario, L., Burn, J., Capella, G., et al. (2013) · Gut

Genetic factors in colorectal cancerBRCA gene mutations in cancer

Cited by 746

Management of patients with increased risk for familial pancreatic cancer: updated recommendations from the International Cancer of the Pancreas Screening (CAPS) Consortium

Goggins, M., Overbeek, K. A., Brand, R., Syngal, S., Del Chiaro, M., Bartsch, D. K., Bassi, C., Carrato, A., Farrell, J., Fishman, E. K., et al. (2020) · Gut

Pancreatic and Hepatic Oncology ResearchPancreatitis Pathology and Treatment

Cited by 659

Benefit of surveillance for pancreatic cancer in high-risk individuals: outcome of long-term prospective follow-up studies from three european expert centers

Vasen, H., Ibrahim, I., Ponce, C. G., Slater, E. P., Matthäi, E., Carrato, A., Earl, J., Robbers, K., van Mil, A. M., Potjer, T., et al. (2016) · Journal of Clinical Oncology

Pancreatic and Hepatic Oncology ResearchPancreatitis Pathology and Treatment

Cited by 344

Health benefits and cost-effectiveness of primary genetic screening for Lynch syndrome in the general population

Dinh, T. A., Rosner, B. I., Atwood, J. C., Boland, C. R., Syngal, S., Vasen, H. F. A., Gruber, S. B., & Burt, R. W. (2011) · Cancer Prevention Research

Genetic factors in colorectal cancerBRCA gene mutations in cancer

Cited by 175

Magnetic Resonance Imaging Surveillance Detects Early-Stage Pancreatic Cancer in Carriers of a p16-Leiden Mutation

Vasen, H. F. A., Wasser, M., van Mil, A., Tollenaar, R. A., Konstantinovski, M., Gruis, N. A., Bergman, W., Hes, F. J., Hommes, D. W., Offerhaus, G. J. A., et al. (2011) · Gastroenterology

Pancreatic and Hepatic Oncology ResearchMRI in cancer diagnosis

Cited by 152

Pancreatic Cancer Surveillance in Carriers of a Germline CDKN2A Pathogenic Variant: Yield and Outcomes of a 20-Year Prospective Follow-Up

Klatte, D. C. F., Boekestijn, B., Wasser, M. N. J. M., Feshtali Shahbazi, S., Ibrahim, I. S., Mieog, J. S. D., Luelmo, S. A. C., Morreau, H., Potjer, T. P., Inderson, A., et al. (2022) · Journal of Clinical Oncology

Pancreatic and Hepatic Oncology ResearchPancreatitis Pathology and Treatment

Cited by 102

Refinement of screening for familial pancreatic cancer

Bartsch, D. K., Slater, E. P., Carrato, A., Ibrahim, I. S., Guillen-Ponce, C., Vasen, H. F. A., Matthäi, E., Earl, J., Jendryschek, F. S., Figiel, J., et al. (2016) · Gut

Pancreatic and Hepatic Oncology ResearchPancreatitis Pathology and Treatment

Cited by 85

Cost‐effectiveness of pancreas surveillance: The CDKN2A ‐p16‐ Leiden cohort

Ibrahim, I. S., Vasen, H. F. A., Wasser, M. N. J. M., Feshtali, S., Bonsing, B. A., Morreau, H., Inderson, A., de Vos tot Nederveen Cappel, W. H., & van den Hout, W. B. (2023) · United European Gastroenterology Journal

Pancreatic and Hepatic Oncology ResearchHealth Systems, Economic Evaluations, Quality of Life

Cited by 17

Pancreatic cancer-associated gene polymorphisms in a nation-wide cohort of p16-Leiden germline mutation carriers; a case–control study

Potjer, T. P., van der Stoep, N., Houwing-Duistermaat, J. J., Konings, I. C. A. W., Aalfs, C. M., van den Akker, P. C., Ausems, M. G., Dommering, C. J., van der Kolk, L. E., Maiburg, M. C., et al. (2015) · BMC Research Notes

Pancreatic and Hepatic Oncology ResearchGenetic factors in colorectal cancer

Cited by 15

Dilatation of the main pancreatic duct as first manifestation of small pancreatic ductal adenocarcinomas detected in a hereditary pancreatic cancer surveillance program

Vasen, H. F. A., Boekestijn, B., Ibrahim, I. S., Inderson, A., Bonsing, B. A., de Vos tot Nederveen Cappel, W. H., Feshtali, S., & Wasser, M. N. (2019) · HPB

Pancreatic and Hepatic Oncology ResearchPancreatitis Pathology and Treatment

Cited by 12